Effect of a gonadotropin-releasing hormone analogue on the glucose metabolism in a diabetic patient
Case report
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Treatment of endometriosis with a GnRH analogue (leuprolide acetate/Depo-Lurpon) was associated with hyperglycemia and worsened glucose control in an insulin-dependent diabetic patient.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
We report a case of an insulin-dependent diabetic female who received leuprolide acetate and Depo-Lurpon for the treatment of endometriosis. Their use was associated with hyperglycemia and a deterioration in glucose control that necessitated changes in insulin dosage.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient 1998
- Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders 1994
- Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature 2008
Cited by (3)
- Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature 2008
- A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient 1998
- Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders 1994
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:08:28.697392+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00
License: CC0
· commercial use OK